Upgrade to SI Premium - Free Trial

Eli Lilly (LLY) Reiterated at Overweight by Cantor Fitzgerald as Injectable Obesity TRx Down

June 22, 2026 7:37 AM
Cantor Fitzgerald analyst Carter Gould reiterated an Overweight rating and $1,230.00 price target on Eli Lilly (NYSE: LLY).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments